A study to assess vedolizumab concentrations in tissue of ulcerative colitis patients and to correlate with their inflammatory state and serum level
Latest Information Update: 10 Jul 2020
At a glance
- Drugs Vedolizumab (Primary)
- Indications Ulcerative colitis
- Focus Pharmacokinetics
- 10 Jul 2020 New trial record
- 19 May 2020 Results published in Gasteroenterology in conjunction with Digestive Disease Week 2020